内容摘要：for the town of about 1,300 people and the surrounding area.

for the town of about 1,300 people and the surrounding area.

A shot from the point through traffic won Game 1 in overtime for the Hurricanes. A shot to the short side went in to put Carolina up 2-0 in Game 3. Then Thompson couldn’t hold onto a glove save in Game 4, and a goal off the rebound gave the Hurricanes a two-goal lead in that one.Thompson did make some big stops — including a lunging stick save on Logan Stankoven on Thursday — that helped keep the Capitals in games. Washington managed only seven goals in the series, so when Carolina did score, the impact was magnified.

And thus ended the Capitals’ most successful season since they won the Stanley Cup in 2018. They made the playoffs a year ago — barely — and were swept immediately by the New York Rangers. Not much more was expected in 2024-25, but Washington celebrated its 50th-anniversary season in style, finishing atop the Eastern Conference standings and helping OvechkinThe Capitals dispatched Montreal in five games before facing a Carolina team that pressured them from the start and never allowed Washington to get comfortable.“It’s tough obviously. We had a special group,” Ovechkin said. “I don’t think we played bad hockey. We had lots of great chances to get the lead. It’s tough.”

Ovechkin scored one goal in the series against Carolina after contributing four in the first round and 44 during the regular season.“For him to come back this year and play the way that he did, chase down this record, start that he had,

, coming back from that, and just continuing to not only do the things he did individually statistically, but lead our team,” coach Spencer Carbery said. “It’s why people are going to look at this team and go, ‘How did this team do so well? How did they win the East?’ He’s a big part of that.”

Ovechkin turns 40 in September. Carbery was asked if he expects his star back next season.Genetic testing companies such as GeneDx have made some headway in screening more people of diverse backgrounds, but inequities remain.

For example, comprehensive data about cystic fibrosis is scarce among African populations – affecting people who live on the continent as well as those who trace their ancestry there.Black cystic fibrosis patients are more likely than their white counterparts to be among the 10% who don’t benefit from modulator therapies.

While there’s little chance of changing market dynamics, researchers said, one solution is to develop “mutation agnostic” gene therapies targeting all patients with a disease. This approach is being tried in diseases of the retina as well as cystic fibrosis.“There’s a huge push to develop these therapies,” said Dr. Garry Cutting of the Johns Hopkins Cystic Fibrosis Center.